Nexperia

Nexperia has announced its financial results for the third quarter of 2026. Building on the progress achieved during the first half of 2026, Nexperia delivered another consecutive quarter of revenue growth in Q3, supported by recovering customer demand and production capacity. Revenue reached $389 million, up 9.3% compared with Q2 2026 ($356 million), with broad-based

Nexperia announced its financial results for the first quarter of 2026, demonstrating resilient performance in a challenging operating environment. Despite supply chain constraints, including the loss of control over Nexperia’s operations in China and local management’s refusal to comply with Nexperia’s processes, Nexperia nevertheless maintained operational stability and delivered solid financial performance through financial discipline